StonvexLoading…
StonvexStonvexStonvexCore line items from IRM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $6.90B | $6.15B | $5.48B | $5.10B |
Operating Income | $1.16B | $1.01B | $921.78M | $1.05B |
Net Income | $152.25M | $183.67M | $187.26M | $562.15M |
EPS (Diluted) | $0.49 | $0.61 | $0.63 | $1.90 |
Total Assets | $21.13B | $18.72B | $17.47B | $16.14B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $158.53M | $155.72M | $222.79M | $141.80M |
Free Cash Flow OCF − CapEx | $-931.63M | $-594.86M | $-225.66M | $52.32M |
Shares Outstanding | 295.79M | 293.59M | 292.14M | 290.83M |